Regional variations of rates and determinants of drug resistance mutations in people failing first-line therapy for HIV-1: a substudy from the D2EFT phase 3b/4 clinical trial

Journal:

Clinical Infectious Diseases

Published:

2026-01-03

DOI:

10.1093/cid/ciaf739

Affiliations:

15

Authors:

22

Go to article

Institutions	Authors	Share
University of New South Wales (UNSW Sydney), Australia	7.000000	0.32
Hospital J. M. Ramos Mejía, Argentina	2.000000	0.09
Khon Kaen University, Thailand	1.000000	0.05
University of Malaya (UM), Malaysia	1.000000	0.05
Indonesia Research Partnership on Infectious Diseases (INA-RESPOND), Indonesia	1.000000	0.05
Chennai Antiviral Research and Treatment Clinical Research Site (CART CRS), India	1.000000	0.05
Fundación Arriarán, Chile	1.000000	0.05
Desmond Tutu Health Foundation (DTHF), South Africa	1.000000	0.05
Donka Hospital, Guinea	1.000000	0.05
Institute of Human Virology, Nigeria (IHVN), Nigeria	1.000000	0.05
University of Zimbabwe (UZ), Zimbabwe	1.000000	0.05
Cipto Mangunkusumo General Hospital, Indonesia	1.000000	0.05
National Hospital Abuja, Nigeria	1.000000	0.05
Dr. Soetomo General Hospital Surabaya, Indonesia	1.000000	0.05
Dr. Sardjito Hospital, Indonesia	1.000000	0.05

Interested in Clinical Sciences?